IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) reminds investors in CorMedix, Inc. (“CorMedix” or the “Company”) (NYSE: CRMD), who purchased or otherwise acquired shares between March 12, 2011 and July 29, 2015, inclusive (the “Class Period”), of the September 4, 2015, deadline to serve as lead plaintiff in the class action. If you purchased shares of CorMedix during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd